Targeting type I interferon-mediated activation restores immune function in chronic HIV infection.

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Chronic immune activation, immunosuppression, and T cell exhaustion characterize HIV infection.
• Type I interferons (IFN-I) are implicated in persistent immune activation during HIV.
• Mechanisms driving these immune dysfunctions in HIV remain incompletely understood.

Purpose of the Study:

• To investigate the impact of blocking IFN-I signaling on T cell responses and viral replication in a murine model of chronic HIV infection.
• To evaluate the efficacy of combining IFN-I blockade with antiretroviral therapy (ART) for HIV treatment.

Main Methods:

• Utilized a humanized mouse model of chronic HIV infection.
• Administered in vivo blockade of IFN-I signaling.
• Assessed T cell activation, exhaustion markers, HIV-specific CD8 T cell function, and viral replication.
• Evaluated the combination of IFN-I blockade with ART.

Main Results:

• In vivo IFN-I blockade diminished HIV-driven immune activation and decreased T cell exhaustion markers.
• IFN-I blockade restored HIV-specific CD8 T cell function and reduced viral replication.
• Combination therapy (ART + IFN-I blockade) accelerated viral suppression and reduced the HIV reservoir compared to ART alone.

Conclusions:

• Blocking IFN-I signaling can restore immune function and reduce viral replication in chronic HIV infection.
• Combining IFN-I blockade with ART shows potential for enhanced viral suppression and reduction of HIV reservoirs.
• IFN-I blockade represents a promising therapeutic strategy for HIV infection, particularly in combination with ART.